Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk

NCT04885933 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.

NCT NCT04885933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk
Lead sponsor
Far Eastern Memorial Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2018
Completion date
June 21, 2020
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation, sarcopenia